Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension

Abstract Background: Vitamin D (Vit D) is linked to various conditions including musculoskeletal, metabolic and cardiopulmonary diseases. However, it is not clear whether correction of vit D deficiency exerts any beneficial effect in patients with pulmonary hypertension. Methods: This...

Patients with Hyperthyroidism May Develop Mild Pulmonary Hypertension, Study Finds

A significant proportion of patients with hyperthyroidism may have mild pulmonary hypertension (PH), according to the results of a recent study. Increased pulmonary vascular resistance may be the underlying cause of this association. The study, “Relationship Among Pulmonary Hypertension,...

Debunking 5 Major Lung Transplant Myths

Professor Daniel Chambers from the Queensland Lung Transplant Service, at The Prince Charles Hospital in Brisbane, Australia, debunks 10 myths about lung transplants for pulmonary hypertension patients and other patients with lung problems. Read about five of the myths here: Lung transplant was considered “revolutionary” when...

Right Ventricle Dysfunction in PAH May Be Treated by Drug Targeting a Signaling Pathway Independent of Arterial Pressure

By MAGDALENA KEGEL Blocking the enzyme sphingosine kinase 1 (SK1) reduced right ventricle enlargement in a mouse model of pulmonary arterial hypertension (PAH), while having no impact on blood vessel remodeling. The findings, published in the journalCellular Signalling, highlighted disease...

Researchers Identify 2 Possible Blood Biomarkers of PAH Progression and Severity

By Patricia Inacio, PhD Galectin-3 (Gal-3) and the hormone aldosterone are two potentialbiomarkers for disease progression in patients with pulmonary arterial hypertension, according to a recent study, “Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension,” published in the journal...